Kiran K Andra, PhD - SUNY at Buffalo

Kiran K Andra

PhD

SUNY at Buffalo

Buffalo, New York | United States

Kiran K Andra, PhD - SUNY at Buffalo

Kiran K Andra

PhD
Introduction

Primary Affiliation: SUNY at Buffalo - Buffalo, New York , United States

Metrics

7

Publications

73

Profile Views

11

Reads

20

PubMed Central Citations

Publications

7Publications

11Reads

20PubMed Central Citations

Structural mapping of fluorescently-tagged, functional nhTMEM16 scramblase in a lipid bilayer.

J Biol Chem 2018 Aug 14;293(31):12248-12258. Epub 2018 Jun 14.

From the Department of Biochemistry, Weill Cornell Medical College, New York, New York 10065 and

View Article
August 2018
1 Read
4.57 Impact Factor

Out-of-the-groove transport of lipids by TMEM16 and GPCR scramblases.

Proc Natl Acad Sci U S A 2018 07 20;115(30):E7033-E7042. Epub 2018 Jun 20.

Department of Anesthesiology, Weill Cornell Medical College, New York, NY 10065;

View Article
July 2018
3 PubMed Central Citations(source)
9.81 Impact Factor

Fluorinated Aromatic Amino Acids and its Therapeutic Applications

Andra, Biochem Anal Biochem 2015, 4:4

Biochemistry & Analytical Biochemistry

Fluorinated amino acids play a significant role in peptides and protein studies. These are known to enhance the stability of proteins folds and serve as valuable analogues for investigation of enzyme kinetics, protein-protein and ligand-receptor interactions. Due to the unique properties of fluorine, fluorinated amino acids are used as a powerful tool to study biological process and to develop anti-cancer reagent and vaccines. Previous reviews cover synthesis and applications of fluorinated amino acids in broad range; this short review provides the importance of fluorinated aromatic amino acids and the impact of fluorine substitution in its aromatic rings that facilitate the study of structure, function and stability of therapeutic proteins and peptides which have great potential for future therapeutic applications.

View Article
December 2015
1 Read

Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine.

Hum Vaccin Immunother 2013 Nov 7;9(11):2362-70. Epub 2013 Aug 7.

Macromolecule and Vaccine Stabilization Center; Department of Pharmaceutical Chemistry; University of Kansas; Lawrence, KS USA; Bioengineering Graduate Program; University of Kansas; Lawrence, KS USA.

View Article
November 2013
5 Reads
3 PubMed Central Citations(source)
2.13 Impact Factor

Comparison of the structural stability and dynamic properties of recombinant anthrax protective antigen and its 2-fluorohistidine-labeled analogue.

J Pharm Sci 2012 Nov 21;101(11):4118-28. Epub 2012 Aug 21.

Macromolecule and Vaccine Stabilization Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA.

View Article
November 2012
2 Reads
5 PubMed Central Citations(source)
2.59 Impact Factor

pH effects on binding between the anthrax protective antigen and the host cellular receptor CMG2.

Protein Sci 2012 Oct 22;21(10):1467-80. Epub 2012 Aug 22.

Department of Chemistry, Wichita State University, Wichita, Kansas 67260-0051, USA.

View Article
October 2012
2 Reads
5 PubMed Central Citations(source)
2.85 Impact Factor

2-Fluoro-l-histidine.

Acta Crystallogr Sect E Struct Rep Online 2010 Oct 2;66(Pt 11):o2713. Epub 2010 Oct 2.

Department of Chemistry, Wichita State University, 1845 Fairmount, Wichita, KS 67260-0051, USA.

View Article
October 2010
1 Read
4 PubMed Central Citations(source)